Kolinpharma Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Rita Petrelli
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 3.8yrs |
Recent management updates
Recent updates
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital
Jun 17
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?
Dec 01An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued
Aug 25We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt
Jun 08Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?
May 21Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?
May 03Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio
Apr 13What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?
Feb 20Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Dec 28These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well
Nov 22CEO
Rita Petrelli
no data
Tenure
Dr. Rita Paola Petrelli is the Co-Founder, Chairwoman of The Board, Chief Executive Officer and Chief Financial Officer of Kolinpharma S.p.A. Dr. Petrelli is chartered accountant, auditor and technical-leg...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | no data | no data | no data | |
| CEO & Director | 4.4yrs | no data | no data | |
| Independent Director | no data | no data | no data | |
| Chairman of the Board of Statutory Auditors | 3.8yrs | no data | no data | |
| Non-Executive Director | no data | no data | no data | |
| Non-Executive Director | no data | no data | no data | |
| Independent Director | no data | no data | no data | |
| Standing Auditor | 3.8yrs | no data | no data | |
| Standing Auditor | 3.8yrs | no data | no data |
3.8yrs
Average Tenure
Experienced Board: KIP's board of directors are considered experienced (3.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/01 09:39 |
| End of Day Share Price | 2023/09/27 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kolinpharma S.p.A. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Luigi Tardella | EnVent Capital Markets Limited |
| Luisa Primi | IR Top Consulting S.r.l. |